Microport Cardioflow Medtech Corp
HKEX:2160

Watchlist Manager
Microport Cardioflow Medtech Corp Logo
Microport Cardioflow Medtech Corp
HKEX:2160
Watchlist
Price: 0.93 HKD 1.09% Market Closed
Market Cap: 2.2B HKD

Microport Cardioflow Medtech Corp
Investor Relations

MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

Show more
Loading
2160
Hang Seng (Hong Kong)

Earnings Calls

No Earnings Calls Available

Management

Mr. Jeffrey R Lindstrom
President, GM & Executive Director
No Bio Available
Mr. Liang Zhao
Executive Director & First VP of Total Solutions
No Bio Available
Ms. Luying Yan
VP & Executive Director
No Bio Available
Ms. Lok Yee Chan A.C.I.S., A.C.S.
Joint Company Secretary
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District
Contacts